Cargando…

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy

The human interferon (IFN) response is a key innate immune mechanism to fight virus infection. IFNs are host-encoded secreted proteins, which induce IFN-stimulated genes (ISGs) with antiviral properties. Among the three classes of IFNs, type III IFNs, also called IFN lambdas (IFNLs), are an essentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruening, Janina, Weigel, Bettina, Gerold, Gisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309426/ https://www.ncbi.nlm.nih.gov/pubmed/28255563 http://dx.doi.org/10.1155/2017/7232361

Ejemplares similares

Decoding protein networks during virus entry by quantitative proteomics
por: Gerold, Gisa, et al.
Publicado: (2016)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells
por: Banse, Pia, et al.
Publicado: (2018)

Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB
por: Bruening, Janina, et al.
Publicado: (2018)

Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
por: Gerold, Gisa, et al.
Publicado: (2015)

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
por: Gerold, Gisa, et al.
Publicado: (2013)

Role of viral and host factors in interferon based therapy of hepatitis C virus infection
por: Imran, Muhammad, et al.
Publicado: (2013)

Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus
por: Bender, Silke, et al.
Publicado: (2015)

Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells
por: Alberione, María Pía, et al.
Publicado: (2020)

Hepatitis E virus persists in the presence of a type III interferon response
por: Yin, Xin, et al.
Publicado: (2017)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
por: Sung, Pil Soo, et al.
Publicado: (2018)

Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection
por: Singal, Ashwani Kumar
Publicado: (2010)

Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
por: Figlerowicz, Magdalena, et al.
Publicado: (2010)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

ID: 101: Investigating the role of interferon λ4 in hepatitis C virus infection
por: Terczynska-Dyla, Ewa, et al.
Publicado: (2015)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Hepatitis C Virus Infection: Looking for Interferon Free Regimens
por: González-Moreno, J., et al.
Publicado: (2013)

Type III Interferons: Emerging Roles in Autoimmunity
por: Manivasagam, Sindhu, et al.
Publicado: (2021)

Cholesterol sensing by CD81 is important for hepatitis C virus entry
por: Palor, Machaela, et al.
Publicado: (2020)

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection
por: Venugopal, Vishnu, et al.
Publicado: (2018)

Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection
por: Wong, Mun-Teng, et al.
Publicado: (2016)

ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production
por: Vieyres, Gabrielle, et al.
Publicado: (2016)

Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection
por: Basar, Omer, et al.
Publicado: (2021)

Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin
por: Wu, Chia-Min, et al.
Publicado: (2021)

The Role of Interferon in Hepatitis B Therapy
por: Rijckborst, Vincent, et al.
Publicado: (2010)

Roles of Type I and III Interferons in COVID-19
por: Choi, Hojun, et al.
Publicado: (2021)

Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response
por: Read, Scott A., et al.
Publicado: (2015)

Role of epigenetic modification in interferon treatment of hepatitis B virus infection
por: Yang, Zhijing, et al.
Publicado: (2022)

Distinct Effects of Type I and III Interferons on Enteric Viruses
por: Ingle, Harshad, et al.
Publicado: (2018)

Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy
por: von Schaewen, Markus, et al.
Publicado: (2015)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
por: Barbaglia, Matteo Nazzareno, et al.
Publicado: (2022)

Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection
por: Kim, Ji Hun, et al.
Publicado: (2009)

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
por: von Schaewen, Markus, et al.
Publicado: (2016)

Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
por: Meredith, Luke W, et al.
Publicado: (2014)

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections
por: Lin, Jian-Da, et al.
Publicado: (2016)

Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
por: Portela Sousa, Caciane, et al.
Publicado: (2020)

The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity
por: Carriquí-Madroñal, Belén, et al.
Publicado: (2023)

Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
por: Goyal, Gitanjali, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ntm0nuam3b7c95pg4c65cmuq3d